glp 1 average weight loss first month Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some GLP-1 Weight Loss in St.
Description
J Hepatol 2012;56:952-964

These drugs work by mimicking a natural hormone called glucagon-like peptide-1, or GLP-1 for short

Persistent bloating on semaglutide can create a frustrating paradox

GLP-1 (glucagon-like peptide-1) drugs, such as semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound), have shown some weight loss and cardiometabolic benefits in clinical trials

The study showed a 13% reduction in major adverse cardiovascular events (MACE), a composite endpoint for cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, in patients treated with liraglutide compared with placebo at a mean follow-up of 3.8 years (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.780.97) and a significant reduction in cardiovascular death (HR 0.78, 95% CI 0.660.93)
